companydata.dkcompanydata.dk

PHARMAVIE A/S: Financial statements 2020

CVR: 26553148

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

PHARMAVIE A/S (CVR 26553148) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -173,087 and a net result of DKK 5,910 compared with DKK -1,294,816 the year before. Equity in the 2020 report amounted to DKK 712,202. The solvency ratio was 4.4%. The company had 1 employee in the financial year.

Gross Profit
DKK -173,087
Profit/Loss
DKK 5,910
Equity
DKK 712,202
Total Assets
DKK 16,268,039
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--173K6K712K1
2019--241K-1.3M706K1
2018--240K564K2M-
2017--31K-3.1M1.4M-
2016-66K-743K5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMAVIE A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

PHARMAVIE A/S: The 2019 annual report is outApr 15, 2020

PHARMAVIE A/S has published its annual report for 2019. Gross profit came to DKK -241,481, and the net result was DKK -1,294,816.

About PHARMAVIE A/S

PHARMAVIE A/S is a Danish company of the type Aktieselskab based in Greve, founded in 2002. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named PHARMAVIE CONSULT A/S. The management consists of Carsten Wærn. The board consists of Margit Wærn (chair), Carsten Wærn and Vibeke Wærn. The company is owned by MAW HOLDING ApS and VIPS HOLDING ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 172,767 and a net result of DKK 821,439 compared with DKK 1,603,686 the year before. Equity in the 2025 report amounted to DKK -978,681.

Source: annual report 2025, Danish Business Authority